相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo
C. E. de Bock et al.
PHARMACOGENOMICS JOURNAL (2011)
Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview
Su Golder et al.
PLOS MEDICINE (2011)
EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
K. -L. G. Spindler et al.
ANNALS OF ONCOLOGY (2010)
Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy
Antonia M. Fernandez-Peralta et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer
S. Afzal et al.
ANNALS OF ONCOLOGY (2009)
Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
W. Chua et al.
BRITISH JOURNAL OF CANCER (2009)
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
M. Gusella et al.
BRITISH JOURNAL OF CANCER (2009)
A Study of the MTHFR Gene Polymorphism C677T in Colorectal Cancer
Kristoffer Derwinger et al.
CLINICAL COLORECTAL CANCER (2009)
Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
Michael S. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer
Yue Hong Cui et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis
Elias Zintzaras et al.
PHARMACOGENOMICS (2009)
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients:: A preliminary study
Ming-Yii Huang et al.
BMC CANCER (2008)
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F. Graziano et al.
BRITISH JOURNAL OF CANCER (2008)
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients
Rohini Sharma et al.
CLINICAL CANCER RESEARCH (2008)
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy
Marie-Christine Etienne-Grimaldi et al.
CLINICAL CANCER RESEARCH (2008)
Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer
Marleen I. Gosens et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
Georg Lurje et al.
PHARMACOGENETICS AND GENOMICS (2008)
Research methodology - Reasons or excuses for avoiding meta-analysis in forest plots
John P. A. Ioannidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A. Ruzzo et al.
PHARMACOGENOMICS JOURNAL (2008)
The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer
O. Capitain et al.
PHARMACOGENOMICS JOURNAL (2008)
Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
G>C SNP of thymidylate synthase with respect to colorectal cancer
Milena Gusella et al.
PHARMACOGENOMICS (2007)
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey
John P. A. Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity
Hyun-Jung Cho et al.
THERAPEUTIC DRUG MONITORING (2007)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
Annamaria Ruzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels
Henkjan Gellekink et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation
Salvatore Terrazzino et al.
PHARMACOGENETICS AND GENOMICS (2006)
Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen
Wataru Ichikawa et al.
CLINICAL CANCER RESEARCH (2006)
Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents
A Yawata et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil
E Hitre et al.
PHARMACOGENETICS AND GENOMICS (2005)
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity
A Jakobsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy
T Lecomte et al.
CLINICAL CANCER RESEARCH (2004)
Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients
MC Etienne et al.
PHARMACOGENETICS (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels
BN Trinh et al.
HUMAN GENETICS (2002)
Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer
DJ Park et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2002)
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
B Iacopetta et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
